Wenming Cao
11PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Nov 15, 2024
High chromosomal instability is associated with higher 10-year risks of recurrence for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: clinical evidence from a large-scale, multiple-site, retrospective study.Yu-Yang Liao, Jianfei Fu, Xiang Lu
|Apr 12, 2024
HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis.Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan
|Dec 14, 2023
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial.Yabing Zheng, Wen-Ming Cao, Xiying Shao
|May 10, 2023
Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer.Ziyan Yang, Jianguo Feng, Ji Jing
|Dec 08, 2022
BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers.Jie Sun, Futao Chu, Jiani Pan
Pageof 2